Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-116934
Filing Date
2024-11-12
Accepted
2024-11-12 17:20:49
Documents
2
Period of Report
2024-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2428278d1_6k.htm 6-K 8443
2 EXHIBIT 99.1 tm2428278d1_ex99-1.htm EX-99.1 41138
  Complete submission text file 0001104659-24-116934.txt   50680
Mailing Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1
Business Address 121 RICHMOND STREET WEST PENTHOUSE SUITE 1300 TORONTO A6 M5H 2K1 27744604171
PSYENCE BIOMEDICAL LTD. (Filer) CIK: 0001985062 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-41937 | Film No.: 241449945
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)